Treatment of two patients with Herlitz junctional epidermolysis bullosa with artificial skin bioequivalents

Journal of Pediatrics

Volumn 141, Issue 4, 2002, Pages 553-559

  Jiang, Qiu Jie ^a,b,c   Izakovic, Jan ^a,b,c   Zenker, Martin ^a,b,c   Fartasch, Manige ^a,b,c   Meneguzzi, Guerrino ^a,b,c   Rascher, Wolfgang ^a,b,c   Schneider, Holm ^a,b,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN LAMB3; UNCLASSIFIED DRUG;

ANEMIA; ARTICLE; ARTIFICIAL SKIN; AUTOGRAFT; BIOEQUIVALENCE; BODY FLUID; CASE REPORT; DEHYDRATION; DNA DETERMINATION; EPIDERMIS CELL; EPIDERMOLYSIS BULLOSA; FEMALE; GENE MUTATION; GENE THERAPY; HEMOGLOBIN DETERMINATION; HOMOZYGOTE; HUMAN; HYPOPROTEINEMIA; INFANT; IRON BLOOD LEVEL; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; SKIN BIOPSY; SKIN CULTURE; SKIN GRAFT; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; WEIGHT GAIN; WOUND CARE; WOUND HEALING;

EID: 0036799273     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.127794     Document Type: Article

References (22)

1. Fine JD, Bauer EA, McGuire J, Moshell A. Epidermolysis bullosa. Clinical, epidemiologic, and laboratory advances and the findings of the National Epidermolysis Bullosa Registry. Baltimore (MD): John Hopkins University Press; 1999.
2. Eady RA. Epidermolysis bullosa: scientific advances and therapeutic challenges. J Dermatol 2001;28:638-40.
3. Lin AN. Management of patients with epidermolysis bullosa. Dermatol Clin 1996;14:381-7.
4. Falabella AF, Schachner LA, Valencia IC, Eaglstein WH. The use of tissue-engineered skin (Apligraf) to treat a newborn with epidermolysis bullosa. Arch Dermatol 1999;135:1219-22.
5. Falabella AF, Valencia IC, Eaglstein WH, Schachner LA. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol 2000;136:1225-30.
6. Verrando P, Hsi BL, Yeh CJ, Pisani A, Serieys N, Ortonne JP. Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes. Exp Cell Res 1987;170:116-28.
7. Marinkovich MP, Lunstrum GP, Burgeson RE. The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J Biol Chem 1992;267:17900-6.
8. Gagnoux-Palacios L, Vailly J, Durand-Clement M, Wagner E, Ortonne JP, Meneguzzi G. Functional re-expression of laminin-5 in laminin-γ2-deficient human keratinocytes modifies cell morphology, motility, and adhesion. J Biol Chem 1996;271:18437-44.
9. Pulkkinen L, McGrath JA, Christiano AM, Uitto J, Detection of sequence variants in the gene encoding the β3 chain of laminin 5 (LAMB3). Hum Mutat 1995;6:77-84.
10. Fine JD, Eady RA, Bauer EA, Briggaman RA, Bruckner-Tuderman L, Christiano A, et al. Revised classification system for inherited epidermolysis bullosa: report of the Second International Consensus Meeting on Diagnosis and Classification of Epidermolyis Bullosa. J Am Acad Dermatol 2000;42:1051-66.
11. Basarab T, Dunnill MGS, Eady RAJ, Russell-Jones R. Herlitz junctional epidermolysis bullosa: a case report and review of current diagnostic methods. Pediatr Dermatol 1997;14:307-11.
12. Glazier DB, Zaontz MR. Epidermolysis bullosa: a review of the associated urological complications. J Urol 1998;159:2122-5.
13. Müller H, Bode H, Krone C, Anton-Lamprecht I, Orlowska M. Herlitz syndrome and "pyloric atresia." Helv Paediatr Acta 1989;43:457-66.
14. Hauschild R, Wollina U, Bruckner-Tuderman L. Junctional epidermolysis bullosa gravis (Herlitz): diagnostic and genetic aspects. J Eur Acad Dermatol Venereol 2001;15:73-6.
15. Christiano AM, Pulkkinen L, McGrath JA, Uitto J. Mutation-based prenatal diagnosis of Herlitz junctional epidermolysis bullosa. Prenat Diagn 1997;17:343-54.
16. Roseeuw D, De Raeve L, Dangoisse C, Ramet J. Treatment of epidermolysis bullosa with human cultured epidermal allografts. Dermatology 1994;189:68-70.
17. Fine JD, Johnson L. Efficacy of systemic phenytoin in the treatment of junctional epidermolysis bullosa. Arch Dermatol 1988;124:1402-6.
18. Fridge JL, Vichinsky EP. Correction of the anemia of epidermolysis bullosa with intravenous iron and erythropoietin. J Pediatr 1998;132:871-3.
19. Wilkins LM, Watson SR, Prosky SJ, Meunier SF, Parenteau NL. Development of a bilayered living skin construct for clinical applications. Biotechnol Bioeng 1994;43:747-56.
20. Schmid P, Grenet O, Medina J, Chibout SD, Osborne C, Cox DA. An intrinsic antibiotic mechanism in wounds and tissue-engineered skin. J Invest Dermatol 2001;116:471-2.
21. DeLuca M, Pellegrini G. The importance of epidermal stem cells in keratinocyte-mediated gene therapy. Gene Ther 1997;4:381-3.
22. Uitto J, Eady R, Fine JD, Feder M, Dart J. The DEBRA International Visioning/Consensus Meeting on Epidermolysis Bullosa: summary and recommendations. J Invest Dermatol 2000;114:734-7.